Who are Baker's yeast (Bio Chromium)'s main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/baker-s-yeast-bio-chromium.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Baker's yeast (Bio Chromium) — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Baker's yeast (Bio Chromium) (Baker's yeast (Bio Chromium)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Nutritional supplement / Chromium compound. Area: Endocrinology / Metabolic Disorders.

phase 3 Nutritional supplement / Chromium compound Insulin receptor signaling pathway Endocrinology / Metabolic Disorders Small molecule Live · refreshed every 30 min

Target snapshot

Baker's yeast (Bio Chromium) (Baker's yeast (Bio Chromium)) — Medical Research Foundation, The Netherlands. Baker's yeast enriched with chromium enhances insulin sensitivity and glucose metabolism by providing bioavailable chromium that potentiates insulin signaling.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Baker's yeast (Bio Chromium) TARGET	Baker's yeast (Bio Chromium)	Medical Research Foundation, The Netherlands	phase 3	Nutritional supplement / Chromium compound	Insulin receptor signaling pathway

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Nutritional supplement / Chromium compound class)

Medical Research Foundation, The Netherlands · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Baker's yeast (Bio Chromium) — Competitive Intelligence Brief. https://druglandscape.com/ci/baker-s-yeast-bio-chromium. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab